Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Debt LATEST DEAL TYPE (Cancelled)

Provider of orthopedic medical devices designed for the treatment of musculoskeletal conditions. The company's device is a three-five weekly injection hyaluronic acid (product produced from non-avian sourced material) indicated for the treatment of osteoarthritis knee pain in patients who have failed non-pharmacologic therapy and simple analgesics. The second product, is a three weekly injection hyaluronic acid for the same indication and just launched in January 2019. The company operates with lower costs enabling health care providers and institutions to then reduce their healthcare costs and greater patient access.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 2005 Old Easton Road
  • Suite 207
  • Doylestown, PA 18901
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OrthogenRx’s full profile, request a free trial.

OrthogenRx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Debt - General 16-Jun-2017 Cancelled Profitable
6. Seed Round 14-Jun-2017 00.00 00.000 000.00 Completed Profitable
5. Debt - General 01-Jan-2016 00.00 00.000 Completed Startup
4. Debt - General 05-Jan-2015 00000 00.000 Completed Startup
3. Seed Round 01-Jun-2014 00.00 00.00 Completed Startup
2. Convertible Debt 01-Apr-2014 $900K $900K Completed Startup
1. Grant 31-Oct-2013 $175K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

OrthogenRx Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bioventus Venture Capital-Backed Durham, NC 000 0000 00000000
00000 000000000000 Formerly VC-backed Bedford, MA 000 000000000
000000 0000000 Formerly VC-backed Cambridge, MA 0000 000.00 000000&0 000.00
000000000 Corporation Tokyo, Japan 000
00000 Corporation Turin, Italy 000
To view this company’s complete list of competitors, request access »

OrthogenRx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
New Age Ventures Venture Capital Minority 000 0000 000000 0
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0

OrthogenRx Executive Team (8)

Name Title Board
David Owens Co-Chief Executive Officer, Board Member & Co-President
Michael Daley Ph.D Founder, Board Member, Promoter, Chief Executive Officer and President
Lynne Budnovitch Senior Vice President of Compliance and Corporate Operations
Thomas Petro Chairman
Frank Gallagi Chief Financial Officer

3 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

OrthogenRx Board Members (10)

Name Representing Role Since Contact
David Oster Self Board Member 000 0000
David Owens OrthogenRx Co-Chief Executive Officer, Board Member & Co-President 000 0000
Diane Sullivan Self Board Member 000 0000
Michael Daley Ph.D OrthogenRx Founder, Board Member, Promoter, Chief Executive Officer and President 000 0000
Thomas Petro OrthogenRx Chairman 000 0000

4 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »